Cases & Deals

Nanobiotix completes €28 million rights issue

Clients Nanobiotix SA

Jones Day represented Nanobiotix SA, an oncology focused nanomedicine company, in connection with its €28 million (US$39 million) rights issuance of New Shares.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.